ANDREW BARNER: Open Payments
NPI 1104339670 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,168 in 23 payments from 9 companies in 2025. Trend: 2023 $757 · 2024 $819 · 2025 $2,168
Food & beverage: $2,168
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $474 |
| ABBVIE INC. | 6 | $463 |
| Madrigal Pharmaceuticals | 4 | $418 |
| Janssen Biotech, Inc. | 2 | $280 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $242 |
| Gilead Sciences, Inc. | 1 | $150 |
| GENZYME CORPORATION | 1 | $75 |
| Lilly USA, LLC | 1 | $48 |
| Ethicon US, LLC | 1 | $18 |
Products named: IBSRELA, REZDIFFRA, TREMFYA, XIFAXAN, Livdelzi, SKYRIZI, RINVOQ, MAVYRET.
Industry payments across TX — which companies pay providers there.
